Cochlear | COH

Stock Price
245.64
Daily Change
-9.15 -3.59%
Monthly
-7.03%
Yearly
-19.34%
Q1 Forecast
245.14



Peers Price Chg Day Year Date
Avita Medical 1.10 0.01 0.92% -60.33% Feb/12
Ansell 32.35 -0.95 -2.85% -11.13% Feb/12
Cochlear 245.64 -9.15 -3.59% -19.34% Feb/12
CSL 152.19 -11.25 -6.88% -40.08% Feb/12
Fisher Paykel Healthcare 39.40 0.05 0.13% 12.25% Feb/12
Healius 0.80 -0.06 -6.43% -42.45% Feb/12
Integral Diagnostics 2.47 -0.08 -3.14% -16.84% Feb/12
Mesoblast 2.45 -0.12 -4.67% -15.52% Feb/12
Monash IVF 0.71 -0.01 -1.40% -39.74% Feb/12
Mayne Pharma 2.67 -0.28 -9.49% -51.45% Feb/12

Indexes Price Day Year Date
ASX200 9007 28.70 0.32% 5.47% Feb/12
ASX All Share 9278 -3.50 -0.04% 5.38% Feb/12
AU50 8752 67.70 0.78% 4.35% Feb/12

Cochlear traded at 246.41 this Thursday February 12th, decreasing 8.38 or 3.29 percent since the previous trading session. Looking back, over the last four weeks, Cochlear lost 6.74 percent. Over the last 12 months, its price fell by 19.09 percent. Looking ahead, we forecast Cochlear to be priced at 245.14 by the end of this quarter and at 230.65 in one year, according to Trading Economics global macro models projections and analysts expectations.

Cochlear Limited is an Australian-based company, which provides implantable hearing solutions. The Company designs and offers products and accessories for adults or children. The Company operates through three geographical segments: Americas, EMEA and Asia Pacific. Its products offer various ways to hear, such as automatically adjusting hearing to different environments and streaming sound from a smartphone. It provides various products, including Nucleus sound processors, Smart bimodal hearing solution, Nucleus implants, Nucleus implant reliability, Baha sound processors, Baha implants, Baha Softband, SoundArc. The Company’s accessories include True Wireless devices, Nucleus water-safe accessories, Keeping device in place.